Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roelof van Ewijk

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 31, 2011
[Juvenile spring eruption]Roelof van Ewijk, Chris H Marees
Nederlands Tijdschrift Voor Geneeskunde|November 23, 2012
[Burns in children: child abuse or another cause?]Roelof van Ewijk, Moniek E op de Coul, A H Rian Teeuw, et al.
The Cochrane Database of Systematic Reviews|September 2, 2021
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcomaLianne M Haveman, Roelof van Ewijk, Elvira C van Dalen, et al.
BMC Infectious Diseases|February 17, 2021
Neurologic sequelae of severe chikungunya infection in the first 6 months of life: a prospective cohort study 24-months post-infectionRoelof van Ewijk, Minke H W Huibers, Meindert E Manshande, et al.
The Cochrane Database of Systematic Reviews|September 2, 2021
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcomaLianne M Haveman, Roelof van Ewijk, Elvira C van Dalen, et al.
Insights Into Imaging|January 31, 2023
Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?Cyrano Chatziantoniou, Reineke A Schoot, Roelof van Ewijk, et al.
Cancers|February 9, 2021
The Value of Early Tumor Size Response to Chemotherapy in Pediatric RhabdomyosarcomaRoelof van Ewijk, Bas Vaarwerk, Willemijn B Breunis, et al.
British Journal of Cancer|July 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic reviewAlba Rubio-San-Simón, William Wilson, Giovanna Sironi, et al.
Cancer Treatment Reviews|September 22, 2023
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?Roelof van Ewijk, Morgane Cleirec, Nikolas Herold, et al.
European Radiology|January 24, 2025
The prognostic value of baseline EARL standardized FDG PET indices in pediatric and adolescent high-grade osteosarcomaRoelof van Ewijk, Rana Dandis, Janna Rodewijk, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|March 31, 2011
[Juvenile spring eruption]Roelof van Ewijk, Chris H Marees
Nederlands Tijdschrift Voor Geneeskunde|November 23, 2012
[Burns in children: child abuse or another cause?]Roelof van Ewijk, Moniek E op de Coul, A H Rian Teeuw, et al.
The Cochrane Database of Systematic Reviews|September 2, 2021
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcomaLianne M Haveman, Roelof van Ewijk, Elvira C van Dalen, et al.
BMC Infectious Diseases|February 17, 2021
Neurologic sequelae of severe chikungunya infection in the first 6 months of life: a prospective cohort study 24-months post-infectionRoelof van Ewijk, Minke H W Huibers, Meindert E Manshande, et al.
The Cochrane Database of Systematic Reviews|September 2, 2021
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcomaLianne M Haveman, Roelof van Ewijk, Elvira C van Dalen, et al.
Insights Into Imaging|January 31, 2023
Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?Cyrano Chatziantoniou, Reineke A Schoot, Roelof van Ewijk, et al.
Cancers|February 9, 2021
The Value of Early Tumor Size Response to Chemotherapy in Pediatric RhabdomyosarcomaRoelof van Ewijk, Bas Vaarwerk, Willemijn B Breunis, et al.
British Journal of Cancer|July 29, 2025
Prognostic factors in patients with relapsed high-grade osteosarcoma: a systematic reviewAlba Rubio-San-Simón, William Wilson, Giovanna Sironi, et al.
Cancer Treatment Reviews|September 22, 2023
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?Roelof van Ewijk, Morgane Cleirec, Nikolas Herold, et al.
European Radiology|January 24, 2025
The prognostic value of baseline EARL standardized FDG PET indices in pediatric and adolescent high-grade osteosarcomaRoelof van Ewijk, Rana Dandis, Janna Rodewijk, et al.
Pageof 3